Fast Market Research

New Market Research Report: Global Bipolar Disorder Therapeutic Market 2017-2021

Fast Market Research announces the availability of the new TechNavio report, "Global Bipolar Disorder Therapeutic Market 2017-2021", on their comprehensive research portal


Boston, MA -- (SBWIRE) -- 05/16/2017 -- Bipolar disorder, also called manic-depressive disorder, is a mental disorder that causes unusual mood swings in patients. The disease causes periods of depression and mania in patients.

Technavio's analysts forecast the global bipolar disorder therapeutic market to grow at a CAGR of 2.22% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global bipolar disorder therapeutic market for 2017-2021. To calculate the market size, the report considers the sales of drugs in the bipolar disorder therapeutic market.

The market is divided into the following segments based on geography:


Technavio's report, Global Bipolar Disorder Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Get More Details on this Report and a Full Table of Contents at Global Bipolar Disorder Therapeutic Market 2017-2021

Key vendors

-Eli Lilly
-Bristol-Myers Squibb

Other prominent vendors

-Astellas Pharma
-Janssen Pharmaceuticals

Market driver

-Need to reduce financial burden of bipolar disorder
-For a full, detailed list, view our report

Market challenge

-Lack of adequate diagnostic process
-For a full, detailed list, view our report

Market trend

-Awareness about bipolar disorder in children (pediatric extension)
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan, Astellas Pharma, GlaxoSmithKline, Janssen Pharmaceuticals

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
-Global Bipolar Disorder Partnering 2010-2016
-Global Diabetic Therapeutic Market 2017-2021
-Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016
-Schizoaffective Disorder Global Clinical Trials Review, H2, 2016